Health Catalyst ( (HCAT) ) has shared an announcement.
Health Catalyst is set to acquire Intraprise Health for $43 million, partially paid through issuing over 2 million shares, aiming for a year-end closing. The company also announced the board appointment of Dr. Jill Hoggard Green, enhancing its leadership amid robust Q3 financial performance with revenue of $76.4 million, surpassing guidance. Health Catalyst shows commitment to profitable growth, as seen by increased Adjusted EBITDA guidance for 2024, while continuing to leverage its data and analytics capabilities to drive healthcare improvement.
Learn more about HCAT stock on TipRanks’ Stock Analysis page.
